Cyclosporine Modulation of Multidrug Resistance in Combination with Pravastatin, Mitoxantrone, and Etoposide for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML): A Phase 1/2 Study

Ítems similars

• Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms
  per: Halpern, Anna B., et al.
  Publicat: (2019)
• Mitoxantrone, Etoposide, and Cytarabine (MEC) Following Epigenetic Priming with Decitabine in Adults with Relapsed/Refractory Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms: A Phase 1/2 Study
  per: Halpern, Anna B., et al.
  Publicat: (2017)
• Mitoxantrone and Etoposide for the Treatment of Acute Myeloid Leukemia Patients in First Relapse
  per: Im, Annie, et al.
  Publicat: (2016)
• Prediction of Early Death in Adults with Relapsed or Refractory Acute Myeloid Leukemia
  per: Godwin, Colin D., et al.
  Publicat: (2016)
• Phase 1/2 Trial of GCLAM with Dose-Escalated Mitoxantrone for Newly Diagnosed AML or Other High-Grade Myeloid Neoplasms
  per: Halpern, Anna B., et al.
  Publicat: (2018)